Suppressive activity of alveolar macrophages and blood monocytes from interstitial lung diseases: Role of released soluble factors
- 1 January 1989
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 11 (7) , 751-760
- https://doi.org/10.1016/0192-0561(89)90129-x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Production of an Interleukin-1 Inhibitory Factor by Human Alveolar Macrophages from Normals and Allergic Asthmatic PatientsAmerican Review of Respiratory Disease, 1988
- Correlation between PGE2 production and suppressor activity of alveolar macrophages from patients with interstitial lung diseasesImmunology Letters, 1988
- Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Journal of Clinical Investigation, 1988
- Arachidonic acid metabolism is altered in sarcoid alveolar macrophagesClinical Immunology and Immunopathology, 1987
- Human lymphocytes induce a differential release of prostaglandin E2 and interleukin 1-like mononuclear cell factor from normal blood monocytesEuropean Journal of Immunology, 1984
- Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung.Journal of Clinical Investigation, 1984
- Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production.Journal of Clinical Investigation, 1983
- Human Alveolar Macrophages Suppress the Proliferative Response of Peripheral Blood LymphocytesChest, 1982
- Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay readerJournal of Immunological Methods, 1981
- Regulation of the immune response by prostaglandinsClinical Immunology and Immunopathology, 1980